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Abstract
Staphylococcus aureus is the most common pathogen cultured from
diabetic foot infection including diabetic foot osteomyelitis. This
French multicentre study determined the genetic content of
S. aureus isolated from157consecutive cases admitted to12diabetic
foot centres between 2008 and 2011.We describe for the ﬁrst time
the emergence of theCC398methicillin-susceptible S. aureus clone,
themainclone indiabetic footosteomyelitis, and its tropismforbone.
This clone spreads to humans from an animal source through its
intrinsic virulence. This adaptation of S. aureus isolates looks to be a
worrisome problem and should be carefully monitored.
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Foot ulcers are common in diabetic patients, with a prevalence
as high as 25% [1]. These ulcers frequently become infected, and
spread of infection to soft tissue and bony structures is a major
causal factor for lower-limb amputation [2], making early
diagnosis and adequate treatment essential. Depending on the
setting and severity of infection, prevalence of bone involvement
widely ranges from 10 to 60% [3]. Chronic ulcers of the foot are
at high risk for infection and secondary spread to underlying
bone structures [4]. Consequently, all factors that contribute to
delayed wound healing may increase the risk for developing
diabetic foot osteomyelitis (DFOM). Although Staphylococcus
aureus is the most common pathogen cultured from bone in
DFOM in western countries [5,6], there is currently no report
on the clones of this microorganism in this condition. Staphy-
lococcus aureus clonal complex (CC) 398, which is commonly
found as a colonizing strain in pig farming, is emerging as a cause
of human infections. In recent years, increasing numbers of
studies throughout the world have identiﬁed CC398 strain as a
livestock colonizing strain, but continuously increasing and
alarming cases of human infections have been reported [7]. The
present study reports for the ﬁrst time the emergence of
CC398 strains in a French cohort of patients with diabetic foot
infections (DFI) and its tropism for bone.
Between 1 January 2008 and 31 December 2010, we
prospectively and consecutively screened outpatients attend-
ing one of the 12 participating French foot clinics for DFI. The
local ethics committee (South Mediterranean III) approved this
study. After informed consent was obtained, only patients with
a documented DFI were included if they had not received any
antibiotic agents in the previous month. Patients were
suspected of having osteomyelitis of the foot if they had at
least two of the following clinical criteria: (1) a wound with
duration ≥2 weeks, located over an underlying bony promi-
nence, with an area >2 cm2 or a depth >3 mm; (2) a positive
probe-to-bone test; and (3) abnormalities consistent with the
diagnosis of osteomyelitis either on plain X-rays, radionuclide
procedures (three-phase bone scan and/or labelled leucocyte
imaging) or magnetic resonance imaging. After wound debride-
ment, samples for bacterial culture were obtained by swabbing
the wound base, needle aspiration or tissue biopsy for skin and
soft tissue infection (SSTI) and by transcutaneous bone biopsy
using a previously described procedure [5]. Only patients with
monomicrobial culture for S. aureus were included. Genus,
species and antibiotic susceptibilities were determined using
the Vitek 2 card (BioMerieux, Marcy-l’Etoile, France) and
interpreted according to the recommendations of the French
Society for Microbiology (http://www.sfm-microbiologie.org).
The Alere StaphyType DNA microarray was used according to
protocols that have been previously detailed [8]. This
technology allowed the identiﬁcation of the clonal complex
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(CC) of strains. The afﬁliation of isolates was assessed by an
automated comparison of hybridization proﬁles to a collec-
tion of previously characterized reference strains [8].
Screening for the presence of prophage φSa3 (scn, chp,
pvl, tetM) in CC398 was obtained by DNA array [9,10]. The
presence of each clonal complex in S. aureus strains was
compared according to the clinical condition (DFOM or
SSTI) using Fisher’s exact test. Statistical analysis was
performed using the S-PLUS 2000 software package (Insightful
Corporation, Seattle, WA, USA) and results were consi-
dered signiﬁcant for p <0.05.
During the study period, 157 patients (Table 1) were
recruited, in whom S. aureus was the sole organism isolated
from the bacterial culture of their DFI. Seventy-seven wounds
(49%) were associated with osteomyelitis and 80 with SSTI
without involving the bone. Among the 77 patients, 81
S. aureus isolates were detected; two different S. aureus strains
(a-haemolytic and b-haemolytic colonies) were isolated from
four patients. Prevalence of methicillin-resistant S. aureus
(MRSA) was identical in cultures from DFOM (n = 13, 16%)
and from SSTI (n = 8, 10%). As shown in Table 2, the S. aureus
isolates displayed a high clonal diversity. A total of 18 known
CCs and 11 singletons were identiﬁed. CC398 methicillin-
sensitive S. aureus (MSSA; n = 31) was the most frequently
found CC in DFOM with a prevalence of 38.3% and was
signiﬁcantly associated with this condition (p <0.001). Of the
MSSA strains, 45.6% belonged to the CC398 clone. On the
other hand, CC45 MSSA (n = 13, 16.3%) was signiﬁcantly
associated with SSTI (p 0.05). The antibiotic susceptibilities
showed that the CC398 strains were susceptible to all tested
antibiotics except penicillin G. The strains were isolated in 10
of the 12 foot clinics. No link could be found between each
patient harbouring this clone, suggesting a national propagation
of this strain in DFOM. No relation with animal farming density
or seasonal effect was noted; the clone was distributed
throughout the study period. Interestingly strains with differ-
ent appearances on blood agar media had the same gene
content. Regarding the MRSA strains isolated from DFOM,
they mainly belonged to three CCs: CC8 MRSA (Lyon Clone,
n = 9), the main clone present in French hospitals, CC5 MRSA
(New Paediatric, n = 2) and ST22 MRSA (Barnim Epidemic
Strain, UK-EMRSA-15, n = 1). CC398 strains were character-
ized by some distinctive features regarding the distribution of
virulence factors: absence of enterotoxins, presence of
haemolysins, and genes encoding intracellular adhesion pro-
teins, cap5, together with three genes encoding MSCRAMM
(bbp, clfA, clfB). All the isolates were found in agr group I.
Moreover, the CC398 strains belonged to human MSSA clades
carrying the prophage φSa3 due to the presence of genes
encoding human-speciﬁc immune evasion cluster (chp, n = 29/
TABLE 1. Demographic and clinical characteristics of study patients
Characteristics
Patients with CC398 strains DFOM SSTI Total
n = 31 n = 77 n = 80 n = 157
Age (range), years 66 (38–91) 66 (38–85) 66.5 (33–101) 66.5 (33–101)
Male/female, n (%) 22 (71)/9 (29) 58 (75.3)/19 (24.7) 58 (72.5)/22 (27.5) 116 (73.9)/32 (26.1)
Type 1/type 2 diabetes mellitus 4 (12.9)/27 (87.1) 7 (9.1)/70 (90.9) 14 (17.5)/66 (82.5) 21 (13.4)/136 (86.6)
HbA1c (%) 8.5 8.4 8.4 8.4
Cardiovascular disease
Absence 9 (29.0) 23 (29.9) 16 (20) 39 (24.8)
Coronary heart disease 9 (29.0) 23 (29.9) 31 (38.8) 54 (34.4)
Peripheral arterial disease 18 (58.1) 45 (58.4) 57 (71.3) 102 (65.0)
Arterial hypotension 25 (80.6) 60 (77.9) 65 (81.3) 125 (79.6)
Stroke 1 (3.2) 5 (6.5) 5 (6.3) 10 (6.4)
Nephropathy
Absence 6 (19.4) 15 (19.5) 29 (36.3) 44 (28.0)
Microalbuminuria 6 (19.4) 11 (14.3) 26 (32.5) 37 (23.6)
Proteinuria 10 (32.3) 28 (36.4) 20 (25) 48 (30.6)
Renal failure 9 (29.0) 23 (29.9) 28 (35) 51 (32.5)
Neuropathy
Peripheral 31 (100) 77 (100) 75 (93.8) 152 (96.8)
Autonomic 7 (22.6) 12 (15.6) 20 (25) 32 (20.4)
Diabetic retinopathy
Absence 12 (38.7) 32 (41.6) 31 (38.8) 63 (40.1)
Non-proliferative diabetic retinopathy 13 (41.9) 33 (41.6) 40 (50) 73 (46.5)
Proliferative diabetic retinopathy 6 (19.4) 12 (15.6) 10 (12.5) 22 (14.0)
Lifestyle factors
Obesity 12 (38.7) 31 (40.3) 32 (40) 63 (40.1)
Smoking 8 (25.8) 19 (24.7) 22 (27.5) 41 (26.1)
Alcoholism 5 (16.1) 12 (15.6) 14 (17.5) 26 (16.5)
Sedentary 25 (8.06) 60 (77.9) 62 (77.5) 122 (77.7)
First wound/Recurrence 8 (25.8)/23 (74.2) 17 (22.1)/60 (77.9) 19 (23.8)/61 (76.2) 36 (22.9)/121 (77.0)
IWGDF-IDSA grade
2 (Mild) 0 (0) 0 (0) 38 (47.5) 38 (24.2)
3 (Moderate) 24 (77.4) 54 (70.1) 42 (52.5) 96 (61.1)
4 (Severe) 7 (22.6) 23 (29.9) 0 (0) 23 (14.7)
DFOM, diabetic foot osteomyelitis; HbA1c, glycated haemoglobin; IDSA, Infectious Diseases Society of America; IWGDF, International Working Group of the Diabetic Foot; SSTI,
skin and soft tissue infection.
Values are median and interquartile ranges (25th–75th percentile) or numbers and percentages.
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31 and scn, n = 30/31) and absence of pvl and tetM (associated
with livestock isolates).
The present French multicentre study highlighted for the
ﬁrst time the emergence and spread of CC398 clone in DFI
and its tropism for bone. For many years, this clone has been
described in various livestock and most studies reported
infection with MRSA. As an example, swine have been
identiﬁed as a major reservoir for CC398 MRSA isolates
[11]. Various clinical infections with livestock-associated
CC398 MRSA have been reported around the world [11–
13]. Recently, the emergence of an animal-independent CC398
MSSA clone has been documented in several countries.
However, Price et al. [9] reported that the human CC398s
were the original CC398 clone from which the livestock-asso-
ciated clones emerged. Our strains had a human origin,
indicated by the presence of the human innate immunomod-
ulatory genes carried by φSa3 prophage that plays crucial roles
in human niche adaptation [9,10]. The limited surveillance of
MSSA has precluded an accurate assessment of the global
spread of CC398 [10]. Hence, this emergence was described
in community households in northern Manhattan [12]. Since
that case, some reports have described CC398 MSSA not as a
colonizer but as an infectious agent including cases of
necrotizing pneumonia and invasive bloodstream infections in
young healthy individuals [14,15]. The concern that these
strains may represent a more virulent CC398 subtype is
further supported by the higher prevalence of these strains in
bloodstream infections of patients who had no documented
exposure to livestock [14]. In France this emergence was also
described in bloodstream infections [16]. In addition to the
intrinsic virulence exhibited by CC398 MSSA in previous
studies, the potential to acquire other virulence factors such as
Panton–Valentine leukocidin [17,18], as well as resistance to
multiple classes of antimicrobial drugs [9] warrants reinforced
surveillance. Another animal clone, S. aureus CC97, was
detected in our isolates. This clone was shown to have a
better adaptation to animals than to humans and has been
associated with bovine mastitis [19] with little impact on
humans [20]. In the present study, the two CC97 S. aureus
strains were isolated in DFOM as previously observed [21],
suggesting a bone tropism of these clones of animal origin. The
adaptation of animal S. aureus isolates to humans is a
worrisome problem and should be carefully monitored.
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Appendix 1 Participants of the French Study
Group on Diabetic Foot
University Hospital, N^ımes: Nicole Bouziges, Nathalie Jourdan,
Sophie Schuldiner; University Hospital, Montpellier: Antoine Avignon,
TABLE 2. Distribution of clonal complexes among Staphylo-
coccus aureus strains isolated from diabetic foot osteomyelitis
(DFOM) and skin and soft tissue infection (SSTI) in diabetic
foot ulcers in a French population
Clonal complexes
DFOM
n = 81
SSTI
n = 80
Total
n = 161
p
DFOM vs SSTI
CC398-MSSA 31 (38.3) 4 (5) 35 (21.7) <0.001
CC7-MSSA 4 (4.9) 14 (17.5) 18 (11.2) NS
CC8-MRSA 9 (11.1) 6 (7.5) 15 (9.3) NS
CC45-MSSA 2 (2.5) 13 (16.3) 15 (9.3) 0.05
CC30-MSSA 5 (6.2) 9 (11.3) 14 (8.7) NS
Nonea 7 (8.6) 3 (3.8) 10 (6.2) NS
CC18-MSSA 0 (0) 9 (11.3) 9 (5.6) NS
CC59-MSSA 6 (7.4) 1 (1.3) 7 (4.3) NS
CC25/28-MSSA 0 (0) 7 (8.8) 7 (4.3) NS
CC5-MSSA 4 (4.9) 3 (3.8) 7 (4.3) NS
CC8-MSSA 3 (3.7) 0 (0) 3 (1.9) NS
CC5-MRSA 3 (3.7) 0 (0) 3 (1.9) NS
CC9-MSSA 0 (0) 3 (3.8) 3 (1.9) NS
CC1-MSSA 0 (0) 3 (3.8) 3 (1.9) NS
CC15-MSSA 3 (3.7) 0 (0) 3 (1.9) NS
CC101-MSSA 0 (0) 2 (2.5) 2 (1.2) NS
CC7-MRSA 0 (0) 2 (2.5) 2 (1.2) NS
CC97-MSSA 2 (2.5) 0 (0) 2 (1.2) NS
CC22-MSSA 1 (1.2) 1 (1.3) 2 (1.2) NS
CC22-MRSA 1 (1.2) 0 (0) 1 (0.6) NS
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible
Staphylococcus aureus.
aNone, the clonal complexes of these strains are not known and are absent in
databanks. They correspond to different singletons. NS, not signiﬁcant.
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